PeterHeseltineMD

Infectious Disease • Orange, CA

Professor of Clinical Medicine, UC Irvine

Join to view full profile

Dr. Heseltine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Heseltine's full profile

Already have an account?

Office
200 S Manchester Ave
Suite 514
Orange, CA 92868
Phone+1 714-773-6702
Is this information wrong?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1975 - 1977
Yale-New Haven Medical Center (Waterbury)Residency, Internal Medicine, 1972 - 1975
Albert Einstein College of Medicine/Montefiore (New Rochelle)Internship, Transitional Year, 1971 - 1972
University of Dublin Trinity CollegeClass of 1971

Certifications & Licensure

WI State Medical License 2021 - 2025
TX State Medical License 2021 - 2025
CA State Medical License 1975 - 2024
CT State Medical License 1975 - 1996
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

New Directions in Infection-Associated Ischemic Stroke.
Jin-Man Jung, András Gruber, Peter Heseltine, Kumar Rajamani, Sebastián F Ameriso, Mark J Fisher> ;Journal of Clinical Neurology. 2024 Mar 1
24 citations
The development and application of a high-sensitivity immunoassay for cardiac myosin-binding protein C.
Jack Marjot, Christoph Liebetrau, Robert J. Goodson, Thomas E Kaier, Ekkehard Weber, Peter Heseltine, Michael S. Marber> ;Translational Research. 2016 Apr 1
11 citations
HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
Benedetto Vitiello, Karl Goodkin, Deshratn Ashtana, Paul Shapshak, J. Hampton Atkinson, Peter N.R. Heseltine, Elaine M. Eaton, Robert K. Heaton, William D. Lyman> ;AIDS. 2007 Jul 11
9 citations
Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for ...
Karl Goodkin, Benedetto Vitiello, William D. Lyman, Deshratn Asthana, J. Hampton Atkinson, Peter N. R. Heseltine, Rebeca Molina, Wenli Zheng, Imad Khamis, Frances L. W...> ;Journal of Neurovirology. 2006 Jun 1
34 citations
Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir
Ron M. Kagan, Mark D. Shenderovich, Peter N. R. Heseltine, Kal Ramnarayan> ;Protein Science. 2005 Jul 1
7 citations
New two-amino acid insertion near codon 70 of the HIV type 1 protease gene.
Mark A. Winters, Ron M. Kagan, Peter N. R. Heseltine, Thomas C. Merigan> ;AIDS Research and Human Retroviruses. 2005 Apr 25
4 citations
Rare one and two amino acid inserts adjacent to codon 103 of the HIV-1 reverse transcriptase (RT) affect susceptibility to non-nucleoside RT inhibitors.
Mark A. Winters, Ron M. Kagan, Ladislau C. Kovari, Peter N. R. Heseltine, Thomas C. Merigan> ;Antiviral Therapy. 2005 Jan 1
15 citations
Increasing Prevalence of HIV-1 Reverse Transcriptase Mutation K65R Correlates with Tenofovir Utilization:
Ron M. Kagan, Thomas C. Merigan, Mark A. Winters, Peter N. R. Heseltine> ;Antiviral Therapy. 2004 Jul 1
18 citations
HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization.
Ron M. Kagan, Mark A. Winters, Thomas C. Merigan, Peter N. R. Heseltine> ;AIDS Research and Human Retroviruses. 2004 Jul 5
26 citations
Structure-based phenotyping predicts HIV-1 protease inhibitor resistance
Mark D. Shenderovich, Ron M. Kagan, Peter N. R. Heseltine, Kal Ramnarayan> ;Protein Science. 2003 Aug 1
The use of data mining to investigate a possible quality problem with ultrasensitive HIV viral load data at a large reference laboratory.
Eileen Koski, Peter N. R. Heseltine, Ron M. Kagan, Ann E. Maddo, Jake Geller> ;AMIA ... Annual Symposium Proceedings. AMIA Symposium. 2003 Jan 1
11 citations
Why don't doctors and nurses wash their hands?
Peter N.R. Heseltine> ;Infection Control and Hospital Epidemiology. 2001 Apr 1
63 citations
In Vitro Activities of Nontraditional Antimicrobials against Multiresistant Acinetobacter baumannii Strains Isolated in an Intensive Care Unit Outbreak
Maria D. Appleman, Howard Belzberg, Diane M. Citron, Peter N.R. Heseltine, Albert E. Yellin, James Murray, Thomas V. Berne> ;Antimicrobial Agents and Chemotherapy. 2000 Apr 1
14 citations
Too many or too few hands
Peter N.R. Heseltine> ;Infection Control and Hospital Epidemiology. 1999 Sep 1
56 citations
Randomized Double-blind Placebo-Controlled Trial of Peptide T for HIV-Associated Cognitive Impairment
Peter N.R. Heseltine, Karl Goodkin, J. Hampton Atkinson, Benedetto Vitiello, James Rochon, Robert K. Heaton, Elaine M. Eaton, Frances L. Wilkie, Eugene Sobel, Stephen ...> ;Archives of Neurology. 1998 Jan 1
11 citations
Unrecognized HIV-1 infection in inner-city hospital emergency department patients.
Tippavan Nagachinta, Claudia R. Gold, Fenny Cheng, Peter N.R. Heseltine, Peter R. Kerndt> ;Infection Control and Hospital Epidemiology. 1996 Mar 1
26 citations
University of southern california repeatable episodic memory test
Elizabeth S. Parker, Elaine M. Eaton, S. C. Whipple, P. N. R. Heseltine, T. P. Bridge> ;Journal of Clinical and Experimental Neuropsychology. 1995 Dec 1
13 citations
Pharmacoeconomics of Piperacillin/Tazobactam and Imipenem/Cilastatin in the treatment of patients with intra-abdominal infections
Stanford S. Jhee, Mark A. Gill, Albert E. Yellin, Thomas V. Berne, Peter N.R. Heseltine, Maria D. Appleman> ;Clinical Therapeutics. 1995 Jan 1
47 citations
Pharmacokinetics of meropenem in patients with intra-abdominal infections.
A. Bedikian, Mark P. Okamoto, Randall K. Nakahiro, J. Farino, Peter N.R. Heseltine, Maria D. Appleman, Albert E. Yellin, Thomas V. Berne, Mark A. Gill> ;Antimicrobial Agents and Chemotherapy. 1994 Jan 1
49 citations
Fungemia and Colonization with Nystatin-Resistant Candida rugosa in a Burn Unit
Michael P. Dubé, Peter N.R. Heseltine, Michael G. Rinaldi, Susan G. Evans, Bruce Zawacki> ;Clinical Infectious Diseases. 1994 Jan 1
15 citations
Tissue concentrations of cefepime in acute cholecystitis patients.
Mark P. Okamoto, Mark A. Gill, Randall K. Nakahiro, Alfred Chin, Albert E. Yellin, Thomas V. Berne, David A. Sclar, Catherine A. Knupp, Peter N.R. Heseltine, Maria D. ...> ;Therapeutic Drug Monitoring. 1992 Jun 1
24 citations
Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.
Yana J. Paulson, Thomas M. Gilman, Peter N.R. Heseltine, Om P. Sharma, C. Thomas Boylen> ;Chest. 1992 Jan 1
58 citations
Epidemiological spectrum and current treatment of listeriosis.
Charles E. Cherubin, Maria D. Appleman, Peter N.R. Heseltine, Walid Khayr, Charles W. Stratton> ;Reviews of Infectious Diseases. 1991 Nov 1
18 citations
Analysis of Cefepime Tissue Penetration Into Human Appendix
Mark P. Okamoto, Alfred Chin, Mark A. Gill, Albert E. Yellin, Thomas V. Berne, Peter N.R. Heseltine, Maria D. Appleman, Catherine A. Knupp, D A Sclar> ;Pharmacotherapy. 1991 Sep 10
15 citations
Susceptibility testing of Listeria monocytogenes. A reassessment of bactericidal activity as a predictor for clinical outcome.
Maria D. Appleman, Charles E. Cherubin, Peter N.R. Heseltine, Charles W. Stratton> ;Diagnostic Microbiology and Infectious Disease. 1991 Jul 1
Join now to see all

Hospital Affiliations

UCI HealthOrange, California

PeterHeseltineMD

Dr. Heseltine is on Doximity

Education & Training

Certifications & Licensure

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.